Anti-IL20/ IL-20/ IL10D functional antibody

Anti-IL20/ IL-20/ IL10D functional antibody for cell culture, ELISA & in-vivo assay

Target products collectionGo to IL20/IL20 products collection >>
(antibodies, antigen, VLP, mRNA, ORF viral vector, etc)


Product information

Catalog No.Product NameSpecies Reactivity
GM-Tg-hg-T94482-Ab-1/ GM-Tg-hg-T94482-Ab-2Anti-Human IL20 monoclonal antibodyHuman
GM-Tg-rg-T94482-Ab-1/ GM-Tg-rg-T94482-Ab-2Anti-Rat IL20 monoclonal antibodyRat
GM-Tg-mg-T94482-Ab-1/ GM-Tg-mg-T94482-Ab-2Anti-Mouse IL20 monoclonal antibodyMouse
GM-Tg-cynog-T94482-Ab-1/ GM-Tg-cynog-T94482-Ab-2Anti-Cynomolgus/ Rhesus macaque IL20 monoclonal antibodyCynomolgus/ Rhesus macaque
GM-Tg-felg-T94482-Ab-1/ GM-Tg-felg-T94482-Ab-2Anti-Feline IL20 monoclonal antibodyFeline
GM-Tg-cang-T94482-Ab-1/ GM-Tg-cang-T94482-Ab-2Anti-Canine IL20 monoclonal antibodyCanine
GM-Tg-bovg-T94482-Ab-1/ GM-Tg-bovg-T94482-Ab-2Anti-Bovine IL20 monoclonal antibodyBovine
GM-Tg-equg-T94482-Ab-1/ GM-Tg-equg-T94482-Ab-2Anti-Equine IL20 monoclonal antibodyEquine

Size: 1mg | 10mg | 100mg



Product Description

Catalog No.GM-Tg-hg-T94482-Ab-1/ GM-Tg-hg-T94482-Ab-2; GM-Tg-rg-T94482-Ab-1/ GM-Tg-rg-T94482-Ab-2;
GM-Tg-mg-T94482-Ab-1/ GM-Tg-mg-T94482-Ab-2; GM-Tg-cynog-T94482-Ab-1/ GM-Tg-cynog-T94482-Ab-2;
GM-Tg-felg-T94482-Ab-1/ GM-Tg-felg-T94482-Ab-2; GM-Tg-cang-T94482-Ab-1/ GM-Tg-cang-T94482-Ab-2;
GM-Tg-bovg-T94482-Ab-1/ GM-Tg-bovg-T94482-Ab-2; GM-Tg-equg-T94482-Ab-1/ GM-Tg-equg-T94482-Ab-2
Products NameAnti-IL20 monoclonal antibody
Formatmab
Target NameIL20
Protein Sub-locationSecreted Protein/Potential Cytokines
Category of antibodyFACS/Biofunctional Antibody, Therapeutics Target antibody, Cytokine antibody
Derivation (species)Mouse
CH1+2+3 Isotype
(Receptor identification)
IgG
Type of Light Chain (VD-LC)N/A
Expression platformMammalian Expression
Bioactivity validationBinding affinity is validated by ELISA with recombinant soluble protein antigen. The biofunction of antibodies are validated with in-vitro assay (IC50 or EC50 TBD).
TagFc
Products descriptionPre-made anti-IL20 benchmark inhibitory monoclonal antibody(mab) (blocking antibody inhibitor) is expressed by mammalian cell line as a benchmark antibody for cell culture, ELISA or other affinity binding assay or functional assay development, animal model development, PK/PD model development (Pharmacokinetics & Pharmacodynamic)
Purity Purity: ≥95% (SDS-PAGE)
Application Biological drug disovery including cell culture, assay development, animal model development, PK/PD model development (Pharmacokinetics & Pharmacodynamic) and mechanism of action (MOA) research.
Formulation Lyophilized from sterile PBS, PH 7.4
Storage Store at -20℃ to -80℃ under sterile conditions. Avoid repeated freeze-thaw cycles.

Reference




    Data / case study


    Click to get more Data / Case study about the product.



    Associated products


    CategoryCat No.Products Name
    BiosimilarGMP-Bios-ab-217Pre-Made Fletikumab biosimilar, Whole mAb, Anti-IL20 Antibody: Anti-IL-20/IL10D/ZCYTO10 therapeutic antibody
    Target AntigenGM-Tg-g-T94482-Ag-1Recombinant multi-species IL20/ IL-20/ IL10D protein
    CytokineGM-Tg-g-T94482-Ag-1Interleukin 20 (IL20) protein


    Target information

    Target IDGM-T94482
    Target NameIL20
    Gene ID50604,58181,681112,694689,609203,101096130,515533,100055632
    Gene Symbol and SynonymsIf2d,IL-20,IL10D,IL20,ZCYTO10
    Uniprot AccessionQ9NYY1
    Uniprot Entry NameIL20_HUMAN
    Protein Sub-locationSecreted Protein/Potential Cytokines
    CategoryTherapeutics Target, INN Index, Cytokine Target
    DiseaseN/A
    Gene EnsemblENSG00000162891
    Target ClassificationN/A

    The target: IL20, gene name: IL20, also named as IL-20, IL10D, ZCYTO10. The protein encoded by this gene is a cytokine structurally related to interleukin 10 (IL10). This cytokine has been shown to transduce its signal through signal transducer and activator of transcription 3 (STAT3) in keratinocytes. A specific receptor for this cytokine is found to be expressed in skin and upregulated dramatically in psoriatic skin, suggesting a role for this protein in epidermal function and psoriasis. [provided by RefSeq, Jul 2008].



    About Gmab

    GDU
    GDU



    GMab, developed by GeneMedi, constitutes an advanced library of recombinant monoclonal antibodies, each meticulously designed to target specific molecular entities. Leveraging the sophisticated capabilities of GM’s Taurus™ and LIBRA™ platforms, GMab synthesizes antibodies characterized by high binding affinity, exceptional physicochemical stability, and optimal developability profiles.

    Through expression in mammalian cell lines, GMab has been established as a paradigmatic reference antibody. It holds significance in myriad domains of biological drug discovery, encompassing cellular cultivation, innovative assay methodologies, strategic animal model systematization, in-depth pharmacokinetic & pharmacodynamic (PK/PD) modeling, and intricate mechanism of action (MOA) investigations.